Autoheal's $7.9M seed backs AI agents that diagnose and repair other AI agents

Autoheal, a San Francisco-based developer tools company, has raised $7.9M in seed funding to build software that uses AI agents to evaluate and repair other AI agents.

The round was announced on September 28, 2026. Investors were not disclosed. According to funding tracker AI Funding, the seed is Autoheal's only round to date, bringing its cumulative total to about $8M.

The company's pitch sits in a narrow but increasingly crowded corner of the agentic AI stack. Autoheal builds technology for evaluating and repairing AI agents, with its core approach described as using AI agents to assess and fix other agents. Its customers are teams developing or deploying agentic systems — organizations that need tooling to identify failures and improve reliability once an agent is out of the lab and into production.

That framing puts Autoheal in the emerging market for AI agent quality, testing, and remediation infrastructure, a category that has grown alongside the wave of enterprise agent deployments. As companies move agents from demos into workflows that touch customers and internal systems, the question of how to catch and correct agent errors has become a distinct problem — and, increasingly, a distinct product category.

Autoheal is categorized among AI developer tools companies. The sector's funding leaders are a different breed of business: coding assistants and development platforms such as Cognition, Cursor, Lovable, Replit, Poolside and Supabase have collectively raised hundreds of millions to over a billion dollars each, according to AI Funding's tracker. Autoheal's $7.9M seed is a fraction of those totals, reflecting both its earlier stage and its bet on a narrower layer of the stack — the maintenance and repair of agents rather than their creation.

What the company will do with the new capital is not disclosed in the announcement. Nor is the identity of its backers, a notable omission at a moment when agent infrastructure deals often arrive with named lead investors attached.

Still, the round gives Autoheal a modest runway in a market where the underlying problem — unreliable agents — is only getting larger as adoption widens. Whether remediation tooling becomes a standalone business or a feature absorbed into the platforms that build the agents is an open question the company now has funding to answer.